MAPT and Alzheimer disease: It is well known that AD is characterized by neurodegeneration in hippocampal, cortical regions, and occurrence of a cholinergic imbalance stemming from oxidative stress and inflammation in neurons, resulting in excessive tau phosphorylation and aggregation of amyloid beta (Aβ) in the brain (Kumar et al. 2015).